Projects per year
Personal profile
Education/Academic qualification
Biomedical Sciences, Doctor of Philosophy, Identifying and addressing the gaps impeding fast and accurate phenotypic drug-susceptibility testing of Mycobacterium tuberculosis , University of Antwerp
Award Date: 3-Sept-2024
Biomedical Sciences, Master of Science in Medical Microbiology, Molecular epidemiology of Leptospirosis in central Sri Lanka, University of Peradeniya
Award Date: 6-Oct-2010
Biological Sciences, Bachelor of Science, University of Kelaniya
Award Date: 1-May-2008
Fingerprint
Dive into the research topics where Rupasinghe Arachchige Praharshinie Rupasinghe is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Knowledge gaps impeding Mycobacterium tuberculosis's fast and accurate phenotypic drug-susceptibility testing
Rupasinghe, R. A. P., de Jong, B., Rigouts, L. & Rigouts, L.
12/12/23 → 3/09/24
Project: PhD-project
Research output
-
Refined understanding of the impact of the Mycobacterium tuberculosis complex diversity on the intrinsic susceptibility to pretomanid
Rupasinghe, P., Reenaers, R., Vereecken, J., Rigouts, L., Mulders, W., Niemann, S., Merker, M., Koeser, C. U., Cogneau, S., Omar, S. V., Decroo, T. & de Jong, B., 2024, In: Microbiology Spectrum. 9 p., Spectrum.00070-24.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Reduced critical concentration might not have improved MGIT-based DST’s sensitivity to rifampicin
Rupasinghe, P., de Jong, B., Rigouts, L., Guglielmetti, L., Mitnick, C. D. & Calderon, R., 2024, (E-pub ahead of print) In: Antimicrobial Agents and Chemotherapy. e01701-23.Research output: Contribution to journal › Letter › peer-review
-
Re-evaluation of critical concentrations of antituberculosis fluoroquinolones in the mycobacteria growth indicator tube 960 System
Rupasinghe, R. A. P., Vereecken, J., de Jong, B., Rigouts, L. & Driesen, M., 2023, In: International Journal of Mycobacteriology. p. 316-323 7 p., 144_23.Research output: Contribution to journal › A2: International peer reviewed article (not A1-type) › peer-review
Open AccessFile12 Downloads (Pure) -
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial
Rupasinghe, P., Patil, S. B., Tamirat, M., Khazhidinov, K., Ardizzoni, E., Atger, M., Austin, A., Baudin, E., Bekhit, M., Bektasov, S., Berikova, E., Bonnet, M., Caboclo, R., Chaudhry, M., Chavan, V., Cloez, S., Coit, J. M., Coutisson, S., Dakenova, Z., de Jong, B., & 33 others, 2023, In: Trials. 24, 1, 14 p., 773.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Balancing access to BPaLM regimens and risk of resistance
Van Rie, A., Walker, T. M., de Jong, B., Rupasinghe, P., Riviere, E., Gagneux, S., Supply, P., Dreyer, V., Niemann, S., Goig, G. A. & Cirillo, D. M., 2022, In: Lancet Infectious Diseases. 22, 10, p. 1411-1412 2 p.Research output: Contribution to journal › Comment/debate › peer-review